Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
CGD NOTES
December 07, 2020
The SARS-COV-2/COVID-19 pandemic has created an unprecedented public health challenge, spurring a global race to develop and distribute viable vaccines. By mid-2021, there will likely be multiple licensed vaccines. Although there is an urgent need for these vaccines to be made available, several cri...
Blog Post
November 25, 2020
As COVID-19 vaccines begin to emerge, policymakers around the world are feeling buoyant. Although governments will be the initial recipients of vaccines, their decisions on how to distribute these among their populations will be fundamental for the ultimate recipients: individuals.
Blog Post
November 24, 2020
To understand the impact of the COVID-19 pandemic on re-enrollment for girls and boys, CGD and Malala Fund collaborated to analyze results from a series of rapid surveys that Malala Fund commissioned in Ethiopia, India, Nigeria, and Pakistan. These surveys are among the first (to our knowledge) to e...
Blog Post
November 24, 2020
COVID-19 has highlighted the ways that global public goods play an increasingly important role in the world, in both negative and positive ways. It’s increasingly clear that many of the biggest challenges nations face—and the solutions—won’t be restricted to one nation’s borders. The need for region...
Blog Post
November 09, 2020
This morning, America (and much of the world) woke up to a snippet of terrific news: Pfizer and BioNTech announced their SARS-CoV2 vaccine candidate showed 90 percent efficacy. But for policymakers in low- and middle-income countries, today’s news offers limited cause for celebration—and the Pfizer/...